ArticleJournal of hematology & oncology2021

SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells.

Siret Tahk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.